 |
|
| Presentations |
|
| |
| Meeting |
Authors |
Title |
| 2008 National State of the Science Congress |
Bailey D, Barroso J, Muir A, McHutchison J, Patel K, Jezsik J, Goacher E, Richmond J, Sloane R. |
Trajectories Of Illness Uncertainty And Fatigue In Patients With Chronic Hapatitis C (CHC) Undergoing Watchful Waiting |
| 17th Annual ICSA Applied Statistics Symposium |
Chow SC and Pong AP |
Issues on sample size calculation in clinical research |
| 29th SCT Annual Meeting |
Chow SC |
Two-stage adaptive design with different study endpoints |
| HRS 2008 Scientific Sessions |
Daniel Haithcock, Kevin Jackson, Donald Hegland, Lori Phillips, R.N., Joseph Rybicki, Tristram D. Bahnson |
Evidence of Cardiac Autonomic Ganglion Cross-talk in a Patient with Inappropriate sinus Tachycardia |
| |
Donald Hegland, G. Burkhard. Mackensen, Daniel H. Katz, Kevin P. Jackson,Danny Rivera, Tristram D. Bahnson |
Feasibility of Real-time 3D Transesophageal Echocardiography to Image the Ligamenet of Marshall and Guide Catheter Ablation for Atrial Fibrillation |
| DDW 2008 |
Schiff E, Poordad F, Jacobson I, Flamm S, Bacon B, Lawitz E, Gordon S, McHutchison J, Ghalib R, Poynard T, Sulkowski M, Trepo C, Rizzetto M, Zeuzem S, Marcellin P, Mendez P, Brass C, Albrecht J. |
Role of Interferon Response During Re-Treatment of Null Responders with Boceprevir Combination Therapy: Results of Phase II Trail. |
| |
Sulkowski M, Lawitz E, Shiffman ML, Muir AJ, Galler G, McCone J, Nyberg L, Lee WM, Ghalib R, Schiff E, Galati J, Bacon B, Davis M, Herrine S, Bloomer J, Gibas A, Freilich B, Reindollar R, King J, Rossaro L, Mukhopadhyay P, Noviello S, Pedicone L, Albrecht J, McHutchison J. |
The Ideal (Individualized Dosing Efficacy Versus Flat Dosing To Assess Opitmal Pegylated Interferon Therapy) Phase IIIB Study: Final Results |
| IPSOR 13th Annual International Meeting |
CA Grussemeyer, JY Friedman, JR Spalding, DK Benjamin, C Moran, SD Reed |
C. albicans and C. glabrata bloodstream infections in adults: outcomes and associated costs. |
| |
Lewis EF, Li Y, Pfeffer MA, Solomon SD, Weinfurt KP, Velazquez EJ, Califf RM, Rouleau JL, Kober L, White H, Schulman KA, Reed SD |
Change in Health-Related Quality of Life Following Non-Fatal Cardiovascular Events in Post-Myocardial Infarction Patients. |
| |
Chou CH, Reed SD, Allsbrook JS, Steele JL, Schulman KA, Alexander MJ |
Higher inpatient costs among patients with subarachnoid hemorrhage complicated by vasospasm |
| |
Li Y, Friedman JY, O’Neal B, Griffiths RU, Stryjewski ME, Schulman KA, Inrig JK, Fowler VG Jr, Reed SD |
Inpatient Costs and Clinical Outcomes of S. aureus Bloodstream and Non-bloodstream Infection in Patients with End-Stage Renal Disease: Findings from a Multi-Center Trial. |
| |
Li Y, Friedman JY, Compton KL, Tzeng JP, Schulman KA, Reed SD |
Is There a Learning Curve Associated with Exercise Training in Patients with Heart Failure? |
| PAS 2008 Annual Meeting |
Smith PB, Cohen-Wolkowiez M, Benjamin DK, Cotten CM, Clark RH, Benjamin DK Jr. |
Late Onset Sepsis in the Neonatal Intensive Care Unit. |
| |
DK Benjamin Jr. BJ Stoll, R Goldberg, TJ Walsh for the NICHD Neonatal Research Network |
Neonatal Candidiasis: Epidemiology, Clinical Judgment, and Outcomes |
| |
Wade KC, Wu D, Kaufman DA Ward RM Benjamin DK Hoppu K Adamson PI Gastonguay M, and Barrett JS On behalf of the NICHD Pediatric Pharmacology Research Unit |
Network Population Pharmacokinetics of Fluconazole in Young Infants |
| |
Wade K and Benjamin DK Jr. on behalf of the NICHD Pediatric Pharmacology Research Unit Network |
Novel Opportunistic Trial Design to Facilitate Phase 1 Pharmacokinetic Drug Studies in Neonates |
| |
Walter EB, Dolor RJ, Rowe-West B, Chmielewski K, Kretsinger K, and Allred
NJ |
Cocooning infants: Tdap Immunization for New Parents in the Pediatric
Office |
| |
Smith PB, Walsh TJ, Hope W, Takada A, Kovanda L, Kearns GL, Kaufman D, Sawamoto T, Buell DN, Benjamin DK Jr. |
Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates. |
| |
Katakam LI, Cotten CM, Goldberg RN, Dang CN, Smith PB |
Indomethacin vs. Ibuprofen for Treatment of Patent Ductus Arteriosus. |
| |
Greenberg R, Smith PB, Clark RH, Benjamin DK Jr. |
Traumatic Lumbar Punctures in Young Infants: Test Performance of CSF WBC Count. |
| |
Cohen-Wolkowiez M, Smith PB, Benjamin DK, Cotten CM, Clark RH, Benjamin DK Jr. |
Early Onset Sepsis in Premature and Term Infants. |
| |
Mitchell TE, Smith PB, Goldberg RN, Hillman S, Millington DS, Cotten CM |
Correlation of Blood Caffeine Levels Measured by Tandem Mass Spectrometry With Levels from Routine Clinical Laboratory Analysis |
| |
Schultz ED, Tanaka DT, Goldberg RN, Benjamin DK Jr., Smith PB |
Methicillin-Resistant Staphylococcus aureus Colonization Increases Total Hospital Costs and Prevents New Admissions to the Neonatal Intensive Care Unit |
| |
Bidegain M, Greenberg R, Simmons C, Dang C, Cotten CM, Goldberg RN, Smith PB |
Vasopressin for Refractory Hypotension in Extremely Low Birth Weight Infants. |
| APASL 18th Annual Conference |
Bain V, Kaita K, Marotta P, Yoshida E, Swain M, Bailey R, Patel K, Cronin P, Pulkstenis E, McHutchison J, Subramanian M |
Albainterferon Alfa-2B Dosed At 4-Week Intervals Demonstrates Clinically Meaningful Antiviral Activity In Chronic Genotype 2 Or 3 Hepatitis C Virus Infection: Results Of A Phase 2 Study. |
| |
Benhamou Y, Zeuzem S, Yoshida E, Bain V, Shouval D, Pianko S, Flisiak R, Rehak V, Grigorescu M, Kaita K, Cronin P, Pulkstenis E, Subramanian M, McHutchison J. |
Sustained Virologic Response With Albinterferon Alfa-2b Plus Ribavirin Treatment in IFN-Naïve, Chronic Hepatitis C Genotype 1 Patients. |
| |
Nelson D, Rustgi V, Balan V, Sulkowski M, Davis G, Muir A, Lambiase L, Wiesner R, Dickson R, McHutchison J, Cronin P, Pulkstenis E, Subramanian M. |
Sustained Virologic Response with Albinterferon Alfa-2b/Ribavirin Treatment in Nonresponders to Prior Interferon Therapy. |
| |
Pianko S, Neumann A, Rozenberg L, Zeuzem S, Benhamou Y, McHutchison J, Pulkstenis E, Subramanian M. |
Early Virologic Response With Albinterferon Alfa-2b Dosed q2wk or q4wk Predicts Similarly High Sustained Virologic Response Rate. |
| 2008 ACR Keystone Pediatric Rheumatology Symposium |
Schanberg LE, Sandborg C, Barnhart H, Ardoin SP, Yow E, Ilowite NT, Eberhard A, Levy D, Kimura Y, von Scheven E, Silverman E, Bowyer S, Punaro L, Singer NG, Sherry D, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins G, Brunner HI, Jung L, Soep J, Reed A, Mieszkalski KL |
Associations Between Race/Ethnicity and Clinical SLE Features in the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort |
| |
Schanberg LE, Sandborg C, Ardoin SP, Mieszkalski K, Yow E, Ilowite NT, Eberhard A, Levy D, Kimura Y, von Scheven E, Silverman E, Bowyer S, Punaro L, Singer NG, Sherry D, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins G, Brunner HI, Jung L, Soep J, Reed A, Barnhart H |
Predictors of Increased Carotid Intima Medial Thickness (CIMT) in the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort. |
| ARVO 2008 Annual Meeting |
Csaky KG, Malek G, Herrmann R, Wu F, Saloupis P, Cousins S |
Intravitreal Injection of TNF-alpha Causes Decreased Neurosensory Retinal Function in the Mouse: A Potential Mechanism of Vision Loss in Neovascular AMD in vivo |
| EASL 43rd Annual Meeting |
Rustgi V, Nelson D, Balan V, Sulkowski M, McHutchison J, Fiscells M, Cronin P, Pulkstenis E, Subramanian M |
Antiviral activity and changes in B-lymphocyte stimulator protein levels during treatment with albinterferon alfa-2b/ribavirin prior interferon therapy non-responders |
| |
Neumann Au, Rozenberg L, Bain VG, McHutchison JG, Pulkstenis E, Subramanian GM |
Viral kinetics and pharmacodynamics of albinterferon alfa-2b in interferon-treatment naïve patients with chronic hepatitis C genotype 1 infection |
| |
Neumann AU, Zeuzem S, Yoshida E, Benhamou Y, Pianko S, McHutchison J, Pulkstenis E, Subramanian M |
Predictive value of early antiviral response profile with albinterferon alfa-2b in IFN-naïve , genotype 1 chronic Hepatitis C patients |
| |
Pianko S, Yoshida E, Zeuzem S, Benhamou Y, Bain V, Pulkstenis E, McHutchison J, Subramanian M |
Health-related Quality of life (HRQoL) with albinterferon alfa-2b plus ribavirin in genotype 1, IFN treatment-naïve, chronic hepatitis C patients |
| |
Manns M, Lindsay KL, Gordon SC, Pockros PJ, Haeussinger D, Hadziyiannia S, Schmidt W, Jacobson I, Barcena R, Schiff E, Shaikh OS, Bacon B, Marcellin P, Smith C, McHutchison JG, Deng W, Pedicone LD, Albrecht JK |
Sustained Virologic Response to Peginterferon alfa-2b Predicts Long-Term Clearance of HCV at 5 Year Follow-Up |
| |
Afdhal NH, McHutchison JG, Blackman N, Campbell FM, Theodore D |
Thrombopoietin (TPO) Levels In Patients With Thrombocytopenia And The Effects Of Eltrombopag On Thrombopoietin Levels |
| |
Schiff E, Poordad F, Jacobson I, Flamm S, Bacon B, Lawitz E, Gordon S, McHutchison J, Ghalib R, Poynard T, Sulkowski M, Trepo C, Rizzetto M, Zeuzem S, Marcellin P |
Boceprevir (B) Combination in Null Responders (NR): Response Dependent on Interferon Responsiveness |
| |
McHutchison J, Everson G, Gordon S, Jacobson I, Kauffman R, McNair L, Muir A |
PROVE 1: Results From A Phase 2 Study Of Telaprevir With Peginterferon Alfa-2A And Ribavirin Treatment – Naïve Subjects With Hepatitis C |
| |
Lalezari J, Gane E, Rodriquez-Torres M, Reddy R, DeJesus E, Jacobson I, Nelson D, Everson G, Hill G, Beard A, Symonds WT, Berrey MM, McHutchison JG |
Potent Antiviral Activity of the Nucleoside Inhibitor R7128 in Combination with Standard of Care- Interim Results of R7128 500mg BID |
| |
Afdhal, McHutchison JG, Graham, Wei, Ladin, Hirosawa |
Double Blind crossover study of RI-001 electrical stimulation on fatigue and inflammation in Hepatitis C patients |
| Congress of the German Society for Internal Medicine |
Tillmann HL |
Standard therapy of hepatitis C. 114 |
| ACC 57th Annual Scientific Sessions |
Allen LA, Yager JE, Tulsky JA, Bowers MT, Dodson GC, O’Connor CM, Felker GM |
Factors associated with an optimistic prognostic outlook among heart failure patients |
| |
Allen LA, Turer AT, DeWald T, Gattis-Stough W, Cotter G, O’Connor CM |
A randomized, open-label, controlled trial of furosemide by continuous infusion versus twice-daily injection for the treatment of acute heart failure. |
| |
Flynn KE, Lin L, Ellis S, Fine L, Pina I, Roll SK, Russell S. Schulman KA, Spertus J, Whellan D, Weinfurt KP |
Relationships among The Kansas City Cardiomyopathy Questionnaire and clinical measures in patients with heart failure |
| |
Jeffrey S. Berger, Dianne Gallup, Matthew Roe, Christopher B. Granger, Paul W. Armstrong, R. John Simes, Harvey D. White, Frans Van de Werf, Eric J. Topol, Robert A. Harrington, Robert M. Califf, Richard C. Becker, Pamela S. Douglas |
Sex Differences in Clinical Presentation and Angiographic Data in Acute Coronary Syndromes |
| |
Jeffrey S. Berger, Dianne Gallup, Matthew Roe, Paul W. Armstrong, R John Simes, Harvey D. White, Frans Van de Werf, Eric J. Topol, Christopher B. Granger, Robert A. Harington, Robert M. Califf, Richard C. Becker, Pamela S. Douglas |
Sex-Based Differences in Mortality Following Acute Coronary Syndromes |
| |
Jeffrey S. Berger, Deepak L. Bhatt, Zhengming Chen, J B Jones, Shamir R. Mehta, Marc S. Sabatine, Steven R. Steinhubl, Eric J. Topol, Peter B. Berger |
The Relationship Between Sex, Mortality and Cardiovascular Events Among Patients With Established Cardiovascular Disease: A Meta-Analysis |
| |
Piccini JP, Pieper D, Solomon SD, Al-Khatib S, Van de Werf F, Pfeffer MA, McMurray J, Califf RM, Velazquez EJ |
Predictors of Sudden Cardiac Death Change With Time After Myocardial Infarction: Results From the VALIANT Trial |
| 9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke |
Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, Peterson ED, Fonarow GC |
Utilization of cardiac resynchronization therapy in patients hospitalized with heart failure. |
| 25th Conference on High Frequency Ventilation of Infants & Children |
Mears S, Smith PB, Rice H, Tracy L, Benjamin J, Cotten CM |
Use of High-Frequency Jet Ventilation in Infants with Congenital Diaphragmatic Hernia |
| ASCO 2008 Genitourinary Cancer Symposium |
Armstrong AJ, Tannock IF, Halabi S, De Wit R, Eisenberger M |
The relationship of body mass index and serum testosterone levels with disease outcomes in men with castration-resistant metastatic prostate cancer |
| |
Armstrong AJ, Febbo PG, Creel P, Morris K, Madden J, Turnbull J, Dewhirst M, Major N, George DJ |
A Phase II Study of RAD001 in Men with Hormone Refractory Metastatic Prostate Cancer |
| SCCM 37th Critical Care Congress |
Granger C, Katz J, Kleinschmidt K, Gore JM, Wyman A, Anderson FA, on behalf of the STAT Investigators |
Acute Severe Hypertension is Associated with High Morbidity and Mortality: Interim Results from the STAT Registry |
| HFSA Scientific Sessions 2007 |
Allen LA, Rogers, JG, Warnica JW, DiSalvo TG, Hasan M, Tasissa G, O’Connor CM, Stevenson LW, on behalf of the ESCAPE Investigators and Coordinators |
Who ESCAPED from Randomization to Receive A Pulmonary Artery Catheter? Characterization of the ESCAPE Registry. |
| |
Allen LA, Beth D Weatherley, Olga Milo-Cotter, Gerasimos Filippatos, Leonardo H Reisen, Daniel R Bensimhon, Eduardo G Gronda, Paolo Colombo, G. Michael Felker, Benedetta Fontanella, Christopher M O'Connor, Gadi Cotter, Howard Dittrich, Marco Metra and Eric J Velazquez |
The Natural Course of Symptoms and Signs During Hospitalization for Acute Heart Failure: The Measure-HF Registry. |
| 2007 CNS Annual Meeting |
Chou C, Reed SD, Allsbrook JS, Steele JL, Schulman KA, Alexander MJ. |
Incremental Cost of Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage (SAH). |
| 9th Annual IPOS World Congress |
Jeffery DD, Reeve BB, Tzeng J, Weinfurt KP, Flynn KE, Keefe FJ, Porter LS, Hahn EA, Cella D, and the PROMIS Sexual Function Subcommittee |
The Sexual Function Domain of the NIH PROMIS: A Preliminary Report. |
| |
Flynn KE, Tzeng J, Jeffery DD, Reeve BB, Weinfurt KP, and the PROMIS Sexual Function Subcommittee. |
Conceptualizations of Sexual Functioning and Intimacy Among Cancer Sufferers and Survivors. |
| |
Flynn KE, Weinfurt KP, Seils DM, Burnett CB, Schulman KA, Meropol NJ. |
Decisional Conflict Among Patients Who Accept or Decline Participation in Phase I Oncology Studies. |
| 47th Annual ICAAC |
Smith PB, Walsh TJ, Hope W, Takada A, Kovanda L, Kearns GL, Kaufman D, Sawamoto T, Buell DN, Benjamin DK Jr. |
Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates. |
| |
Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA, Federspiel J, Athan E, Stryjewski ME, Nacinovich F, Marco F, Levine DP, Elliott TS, Fortes CQ, Tornos P, Gordon DL, Utili R, Delahaye F, Corey GR, Fowler VG, Jr., for the ICE-PCS Study Group. |
Emergence of Coagulase Negative Staphylococci as a Cause of Native Valve Endocarditis. |
| |
Corey, GR |
Future Approaches to Therapy for MRSA |
| World Congress of Dermatology |
Olsen, Elise A. |
ISCL/EORTC Proposal For a Revision to the Staging and Classification System of MF/SS |
| |
Olsen, Elise A. |
Mycosis fungoides/Sezary Syndrome: the summary report of ISCL/EORTC meeting |
| |
Olsen, Elise A. |
Minoxidil, anthralin, topical and intralesional steroids |
| |
Olsen, Elise A. |
Female pattern hair loss |
| 21st Annual NACF Conference |
Friedman JY, Hardy C, Morgan-Dewitt E, Reed SD. |
Pattersns of antibiotic use for patients with mild cystic fibrosis. |
| FDA Science Day |
Benjamin DK Jr., Smith PB, Jadhav P, Gobburu JV, Murphy MD, Hasselblad V, Baker-Smith C, Califf RM, Li JS |
Pediatric Antihypertensive Trial Failures: Analysis of Endpoints and Dose Range. |
| 45th Annual IDSA |
Lalani T, Chu VH, Friedman JY, Reed SD, Griffiths RI, Crosslin DR, Masselink LE, Kaye KS, Kanafani ZA, Corey GR, Fowler VG, Jr. |
Clinical Characteristics and Outcomes of Patients with Staphylococcus aureus Bacteremia and Orthopedic Device Infections. |
| |
Ravi J, McHutchison JG, Patel K, Qiang G, Diehl A. |
Investigations of Mechanisms |
| ACEP Research Forum 2007 |
Clem KJ, Glickman SW, Shah A, Finkel MA, Cairns CB, Pietrobon R, Promes SB. |
Identification of factors that enhance career satisfaction among female emergency medicine physicians. |
| |
Chandra A, Cairns CB, Peakcock FA, McCord JM, Gibler B, Peterson ED, Roe M. |
Society of Chest Pain Centers accreditation improves ACC/AHA Guidelines compliance for NSTEMI |
| |
Glickman SW, Peterson EA, Chandra A, Schulman KA, Cairns CB |
Delays in ED fibrinolytic therapy as primary reperfusion therapy for ST-elevation acute myocardial infarction. |
| |
Thornton VL, De Castro LM, Glickman SW, Vanhorn C, Cairns CB. |
Patient-controlled analgesia for sickle cell patients in the emergency department results in early pain management and increased patient satisfaction. |
| |
Stanley L, Rau G, Scism M, Freeman D, Anderson A, Molinar G, Glickman SW, Chandra A, Laskowitz D, Cairns CB. |
Pediatric patients are less likely to be eligible and to consent to participate than adult patients in an acute brain injury study. |
| |
Barrett JA, Glickman SW, Caram LB, Woods CW, Freeman D, Oien C, Anderson A, Molinar G, Suarez J, Cairns CB. |
Utility of triage heart rate and shock index in predicting infection in emergency department patients with systemic inflammatory response syndrome criteria. |
| |
Chandra A, Limkakeng Jr. AT, Glickman SW, Hocker M, Clem KJ, Cairns CB. |
Diagnostic accuracy of pneumonia and timing to antibiotic differ in geriatric patients with pneumonia. |
| |
Limkakeng Jr,. AT, Chandra A, Glickman SW, Cairns CB. |
Unsuspected pulmonary embolism in observation unit patients. |
| 2007 ACG Annual Scientific Meeting |
Smith A, Wolf A, Patel K. |
Encapsulating Peritoneal Sclerosis. |
| 29th Annual SMDM Meeting |
Sanders GD, Galhenage SP, Patel K, Schulman KA, McHutchison JG |
Modeling the Potential Cost-Effectiveness of Adding a Novel STAT-C Agent to Current Standard Therapy in Patients With Genotype 1 Chronic Hepatitis C Infection. |
| |
Weinfurt KP, Seils DM, Tzeng JP, Astrow AB, Schulman KA, Meropol NJ. |
Varieties of "Don't Know" in Expectations of Benefit Among Patients Entering Early-Phase Oncology Trials. |
| 2007 AASLD 58th Annual Meeting |
Rochon, J., Rosson, R, Seeff, L, et al |
A prospective study of the reliability of the RUCAM for assessing causality in Drug-Induced Liver Injury. |
| |
Galhenage SP, Sanders GD, Patel K, Schulman A, McHutchison JG. |
Modeling the potential cost-effectiveness of adding a novel STAT-C agent to current standard therapy in patients with genotype 1 chronic hepatitis C infection. |
| |
Nelson DR, Rustgi VK, Balan V, Sulkowski M, Davis GL, Muir A, Lambiase L, Dickson RC, Wiesner RH, McHutchison JG, Pulkstenis E, Cronin P, Subramanian GM |
Sustained Virologic Response with albinterferon alfa-2b/ ribavirin treatment in prior interferon therapy non-responders. |
| |
Zeuzem S, Yoshida EM, Benhamou Y, Bain VG, Shouval D, Pianko S, Flisiak R, Grigorescu M, Rehak V, Kaita KD, Cronin P, Pulkstenis E, Subramanian GM, McHutchison JG. |
Sustained Virologic Response rates with albinterferon plus ribavirin treatment in IFN-naive, chronic hepatitis C genotype 1 patients. |
| |
Jaconson IM, Everson GT, Gordon SC, Kauffman R, McNair L, Muir A, McHutchison JG. |
Interim Analysis Results from a Phase 2 Study of telaprevir with Peginterferon alfa-2A Ribavirin in Treatment-naive Subjects with hepatitis C. |
| |
Rodriguez-Torres M, Lawitz EJ, McHutchison JG. |
Final Results of Patients Treated with Peg-interferon-Alfa-2A (Peg-IFN) and Ribavirin (RBV) Follow -on Therapy After 28-Day Treatment with the Hepatitis C Protease Inhibitor Telaprevir (VX-950), Peg IFN and RBV. |
| |
Schiff ER, Everson GT, Tsai N, Bzowei NH, Gish RG, McHutchison JG, Jacobson IM, Tong MJ, Jensen DM, Lauer GM, Cruickshank S, Ferraro J, Haller A, Duke R, Rodell T, Apelian D. |
HCV-Specific Cellular Immunity, RNA Reductions, and Normalization of ALT in Chronic HCV Subjects after Treatment with GI-5005, a Yeast-Based Immunotherapy Targeting NS3 and Core: A Randomized Double-Blind, Placebo Controlled Phase 1b Study. |
| |
Patel K, McHutchison JG, Goodman ZD, Theodore D, Webster A, Schultz M, Stancil B, Gartland M, Gardner S. |
Correlation between liver biopsy and FibroSURE during screening for a Phase II study to assess the antifibrotic activity of Farglitizar in chronic hepatitis C infection. |
| |
Pianko S, Yoshida EM, Zeuzem S, Benhamou Y, Bain VG, Pulkenstenis E, McHutchison JG, Subramanian GM. |
Favorable quality of life (QoL) with albinterferon alfa-2b plus ribavirin in genotype 1, IFN- naive, chronic hapatitis C (CHC) patients. |
| |
Yoshida EM, Kaita KD, Zeuzem S, Torbenson M, Pulkstenis E, McHutchison JG, Subramanian GM. |
Prospective comparison of two commercial non- invasive fibrosis serum marker panels( FibroSURE and FibroSpect II) during interferon-based combination therapy in chronic HCV genotype1. |
| |
Reddy R, Rodriguez - Torres M, Gane E, Robson R, Lalezari J, Everson GT, DeJesus E, McHutchison JG, Vargas HE, Beard A, Rodriguez CA, Hill GZ, Symonds W, Berrey M. |
Antiviral Avtivity, Pharmacokinetics, Safety, and Tolerability of R7128, A Novel Nucleoside HCV RNA Polymerase Inhibitor, Following Multiple, Ascending, Oral Doses in Patients with HCV Genotype 1 Infection Who have Failed Prior Interferon Therapy |
| |
Afdhal NH, McHutchison JG, Shiffman ML, Rodriguez-Torres M, Dusheiko GM, Sigal S, White S, Blackman N, Campbell F, Theodore D. |
Eltrobopag Raises Platelet Counts in Two Weeks in Patients with HCV and Significant Thrombocytopenia. |
| |
Zekry A, Walley N, Weale M, Ginsburg G, Goldstein D, McHutchison JG. |
Polymorphisms in Adrenegic Receptors, Adiponcetin and Adiponcetin Receptors Influence Fibrosis Rates and Response to Therapy in Chronic HCV. |
| 2007 ACR/ARHP Scientific Meeting |
Morgan DeWitt E, Lin L, Glick H, Schulman K, Lingala B, Reed S |
Who Receives Biologics For Treatment Of RA? |
| AMIA 2007 Annual Symposium |
Eisenstein EL, Lobach DF, Montgomery P, Kawamoto K, Anstrom KJ |
Evaluating Implementation Fidelity in Health Information Technology Interventions. |
| |
Eisenstein EL, Lobach DF, Montgomery P, Kawamoto K, Anstrom KJ |
Implementation Fidelity: A Framework for Evaluation in the Health Information Technology Field. |
| 2007 Annual HRPP Conference |
Sugarman S, Fortune-Greeley A, Hardy C, Lawlor JS. |
Research Participants’ Reactions to Standard Informed Consent Language |
Past Meetings: 2007 |
| Prostate Cancer Symposium |
Armstrong AJ, Garrett-Mayer ES, Ou Yang Y, et al. |
A baseline prognostic model incorporating PSA kinetics in hormone-refractory metastatic prostate cancer. |
| 2007 SBM Annual Meeting & Scientific Sessions |
Best JL, Siega-Riz AM, Dole N, Everson KR |
Psychological adjustment
and health behaviors in pregnancy by pregravid BMI. |
| 42nd Annual EASL Meeting |
Poynard T, Schiff E, Terg R, Moreno Otero R, Flamm S, Schmidt W, Berg T, Goncales Jr F, Heathcote J, Diago M, McGarrity T, Maieron A, Reichen J, Tanno H, Brandao C, McHutchison J, Silva M, Bedossa P, Deng W, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J |
Predictors of Sustained Viral Response (SVR) in the Retreatment of Previous Interferon/ Ribavirin Non-Responders (NR): Results from the Epic3 Program |
| Pediatric Academic Societies' Annual Meeting |
Ansong A, Smith PB, Benjamin DK, Clark RH, Li JS, Cotten CM, Mangum B, Wade K, Kaufman DA, Benjamin DK Jr |
Group B Streptococcal Meningitis: Cerebrospinal Fluid Parameters in the Era of Intrapartum Antibiotic Prophylaxis. |
|
Khunvichai HM Chu, Garg V, McHutchison J, Lawitz E, Rodriguez M, Kieffer T, Alam J |
Predicting HCV Treatment Duration with an HCV Protease Inhibitor Co-administered with Peg-IFN/RBV by Modeling both Wild-type Virus and Low Level Resistant Variant Dynamics. |
| 20th Annual Southeastern Fracture Symposium 2007 |
Zura RD, Sabesan V, Nichols LA, Dedmond B, Leach P, Jeray K, Obremskey W, Olson SA, Pietrobon R |
The Effect of Timing of Definitive Fixation for Tibial Plateau Fractures with Associated Compartment Syndrome on Infection Rates. |
| |
|
|
|
|
